FDA Allows More E-Cigarettes and Nicotine Pouches Despite Internal Opposition
FDA's tobacco center staff were blindsided by a decision opening the door to allowing more unauthorized e-cigarettes and nicotine pouches onto the U.S. market.
Objective Facts
Senior officials in the FDA's tobacco center were blindsided by a recent decision that opens the door to allowing more unauthorized electronic cigarettes and nicotine pouches onto the U.S. market. The guidelines, posted online earlier this month before former FDA Commissioner Marty Makary resigned, allow companies to launch certain nicotine-based products before they've been fully vetted by regulators. Some FDA officials tasked with enforcing vaping regulations were not consulted on the changes and only learned of them the night before the document was published. The vaping guidelines bypassed a federally required period that allows for public comment and revisions. The FDA published them as a finalized policy hours after media reports surfaced that President Donald Trump had approved a plan to fire Makary.
Left-Leaning Perspective
The Hill reported that former FDA tobacco director Mitch Zeller characterized the new enforcement discretion guidance as "a get out of jail free card for illegal products that remain in the market until FDA finishes its scientific review," calling it "a huge gift to the industry and inconsistent with the law." Brian King, former director of the FDA's Center for Tobacco Products, told The Hill that "it's evident that there's now greater responsiveness to authorizing more tobacco products for sale on particularly flavored products, and also less ability to resist political interference," characterizing this as "really a byproduct of political interference into the regulatory process, which is highly problematic." In his resignation letter, HHS chief spokesperson Rich Danker wrote that senior HHS officials had sought FDA marketing approval of "cigarette flavors that would appeal to children and expose them to nicotine addiction, lung damage and higher risk of cancer," while some "Make America Healthy Again" health influencers like podcaster Alex Clark expressed concerns that the moves "add more fuel to the fire when it comes to stoking fears that MAHA moms have that special interest groups are running the White House." The New Republic documented that eight days after Reynolds American contributed $5 million to a Trump-backed super PAC, Reynolds executives had lunch with Trump at his Florida golf club and pressed him on FDA regulations, prompting Trump to call FDA Commissioner Makary to complain. Left-leaning critics faulted the procedural irregularities: Mitch Zeller noted the FDA skipped the standard process of issuing a draft and allowing public comments before publishing final guidance, which is "alarming" because typically the FDA only goes straight to final guidance if there's a public health emergency.
Right-Leaning Perspective
The Washington Times reported that Makary had overruled his own agency's scientists, who recommended authorizing certain age-gated flavored e-cigarettes, with Makary rejecting the written recommendations of his agency's scientific reviewers before being pressured by President Trump to reconsider. The piece argued that harm reduction—supporting "a lower-risk (but not completely 'safe') alternative to a risky product or behavior"—is a mainstream public health principle, noting that when conservatives previously opposed harm reduction strategies like clean needle exchange, public health advocates chastised them for doing so. Reason magazine's J.D. Tuccille wrote that Makary "let his emotions override his avowed commitment to following the science" by refusing to approve flavors that former smokers prefer, thereby undercutting "the harm-reducing potential of vaping products" and ignoring "the tradeoff between making vapes less appealing to teenagers and encouraging adult smokers to make a switch that could literally save their lives." RealClearHealth argued that prohibitions on flavored vapes drove users to "an unregulated market" with illegal products comprising "over 70% of the market," exposing users to "dangerous chemicals," making Trump's decision to reverse course "smart" since "e-cigarettes, while not healthy, are an important harm-reduction tool to move consumers away from cigarettes." Citizens Against Government Waste praised the FDA's decisions as delivering "a major victory by expanding the number of tobacco harm reduction products," arguing that releasing guidance "to make it easier for other flavored THR products to receive approval in the future" would "promote personal choice and will expand the number of less harmful products that are available to smokers looking to ditch traditional cigarettes."
Deep Dive
The FDA published the finalized vaping guidance after months of complaints about Makary from industry lobbyists close to the White House. The New Republic documented that eight days after Reynolds American contributed $5 million to a Trump-backed super PAC, Reynolds executives had lunch with Trump at his Florida golf club and pressed him on FDA regulations, prompting Trump to call FDA Commissioner Makary to complain. The Conversation reported that Makary's resignation on May 12, 2026, brought to the forefront a heated controversy over fruit-flavored vapes, with rumors that Trump was planning to fire him due to Makary's disagreement with Trump over the FDA's recent approval of two fruit-flavored vapes, with Makary reportedly disagreeing in private with the FDA's decision which came soon after Trump pushed the FDA to move more quickly in approving fruit-flavored vapes. The core tension in this dispute hinges on a fundamental question: Did Makary properly exercise his authority to maintain scientific rigor, or did he improperly block his own agency's scientific consensus? The Washington Times asserts that Makary overruled his own agency's scientists, who recommended authorizing certain age-gated flavored e-cigarettes, with Makary rejecting the written recommendations of his agency's scientific reviewers. Conversely, NBC News reported that Makary saw fruit-flavored e-cigarettes as contributing to the youth vaping epidemic and opposed the FDA authorization, placing him at odds with other Trump administration officials. Left-leaning critics focus on procedural concerns: the FDA skipped issuing a draft and allowing public comments, which is "alarming" because typically the FDA only goes straight to final guidance if there's a public health emergency. Right-leaning critics argue the science supports the policy: the FDA's rigorous scientific review found that Glas's device access restriction technology requiring users to verify age with a government-issued ID and pair the device with a smartphone via Bluetooth is expected to effectively mitigate youth ability to use the product. A critical unresolved question remains: will the enforcement discretion policy actually limit youth access, or will it create the "get out of jail free card" that critics fear? Youth vaping rates have fallen in recent years, with the FDA reporting that the number of middle and high school students who vape dropped from 2.13 million in 2023 to 1.63 million in 2024. This improvement predates the May 2026 policy shift, leaving unclear whether the new guidance will maintain this progress, accelerate it through adult cessation, or reverse it through youth uptake. The next critical test will be whether the age-gating technology actually works in practice and whether the FDA can enforce its new policy as written or whether it becomes, as critics charge, merely a framework that allows products to proliferate pending review completion.